Metabolic Syndrome “Interacts” With COVID-19
Significance statement: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide and has exerted a great influence on public health and society, urging scientists to find efficient therapeutics. Metabolic disturbance involving various organs has been found in these patients, including diabetes, fatty liver, acute kidney injury (AKI), etc. In turn, these preexisting metabolic syndromes could exacerbate COVID-19. In this review, we focus on the close interaction between COVID-19 and metabolic syndrome, as well as the potential of repurposing metabolic-related drugs and the importance of treating metabolic diseases in COVID-19 patients.
Document Type: Original Article
Affiliations: 1: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China 2: Department of Respiratory and Critical Care Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China 3: Division of Vascular Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Publication date: January 1, 2021
This article was made available online on December 22, 2020 as a Fast Track article with title: "Metabolic Syndrome “Interacts” With COVID-19".
- BIO Integration will specifically focus on original, cutting-edge, interdisciplinary contents in the field of biosciences, including medicine, biochemistry, biophysics, bioengineering, biotechnology, etc., which generate hypotheses and questions relevant to the patient and disease and guide the investigations of cellular and molecular medicine. BIO Integration covers new methods, important applications, and new interpretations and treatments of existing data, as well as conventional studies in medicine that can be applied to future theranostic applications.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- BIO Integration Aims and Scope
- BIO Integration Journal Information
- BIO Integration Contact Us
- Ingenta Connect is not responsible for the content or availability of external websites